Fairlea Chiropratic Clinic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 325 Seneca Tr, Ronceverte, WV 24970 Phone: 304-645-6524 Fax: 304-645-6524 |
Mr. Vincent Edward Wardlow, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 631 Edgar Ave, Ronceverte, WV 24970 Phone: 304-645-6524 Fax: 304-645-6527 |
Grose Chiropractic Enterprises Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 118 Taylor Ln, Ronceverte, WV 24970 Phone: 304-645-6524 Fax: 304-645-6527 |
Fairlea Chiropractic Clinic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 8747 Seneca Trl S, Ronceverte, WV 24970 Phone: 304-645-6524 Fax: 304-645-6524 |
Mathew Walton Grose, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 118 Taylor Ln, Ronceverte, WV 24970 Phone: 304-925-1002 |
Harold Raymond Fleschner, DCCRP Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 325 Seneca Trail, Ronceverte, WV 24970 Phone: 304-645-6524 Fax: 304-645-6524 |
News Archive
A team of researchers has found a simple and unique way to considerably reduce stress levels and increase the welfare of monkeys living in a popular zoo.
The Philadelphia Pediatric Medical Device Consortium has announced its latest round of seed grants to companies developing medical devices for children. The Consortium chose two companies from eight finalists in a competition to receive seed grants of $50,000 each.
Men and women who have had contact with the criminal justice system—even if they have never received a jail or prison sentence or a guilty verdict—appear to have a significantly higher rate of suicide than the general population, according to a report posted online today that will appear in the June print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Clearstone Central Laboratories, a leading provider of central laboratory services for late-stage clinical trials, announced today a global collaboration with Laboratory Corporation of America® Holdings through its Esoterix Clinical Trials Services division, providing clients with seamless access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States.
In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.
› Verified 2 days ago